MarginsXMarginsX
Home › Markets › Health Care › SKYE

Skye Bioscience Inc. (SKYE)

SKYE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.06
-2.29% on the day
Market cap
$4.7M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerSKYE on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001516551
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
2.5 months
$8.1M cash at June 30, 2026
Share count, 1 year
+10.4%
2025-11-07 to 2026-11-10 · +186.8% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
-$445K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions give rise to substantial doubt as to the Company's ability to continue as a going concern within one year after the date that these financial statements are issued."
10-Q 2026-11-13
Cash and burn$8.1M cash; operating cash flow -$9.7M a quarter.Report 2026-06-30
Shares outstanding4,423,469 (2026-11-10); 32,057,461 a year earlier; 12,338,910 three years earlier. 1y figure adjusted for splits (1-for-8 overall); 3y figure adjusted for splits (1-for-8 overall).Cover page 2026-11-10
Reverse splits, 3 years1; latest 1-for-8 on 2026-08-24Source 2026-08-24
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-08-19
AuditorCBIZ CPAs P.C., Morristown, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-06-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $445K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$10.8M-$7.1M$8.1M$143KNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$12.5M-$8.6M$8.1M$250KNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$14.4M-$9.8M$5.9M$0Needs four quarters10-K 2026-03-10
Q3 2025
2025-09-30
Not filed-$12.8M-$13.4M$18.4MNo debt tagsNeeds four quarters10-Q 2025-11-10
Q2 2025
2025-06-30
Not filed-$17.6M-$10.7M$23.8MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
Not filed-$11.1M-$9.2M$46.4MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q4 2024
2024-12-31
Not filed-$9.7M-$8.2M$68.4M$0Needs four quarters10-K 2026-03-10
Q3 2024
2024-09-30
Not filed-$3.9M-$5.3M$67.4M$0Needs four quarters10-Q 2025-11-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32024-05-17
Latest annual report10-K2026-03-10
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-11-12

Source: SEC EDGAR submissions feed, 634 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+10.1%
1 month-28.8%
3 months-74.8%
Year to date-81.8%
1 year-90.1%
From 52-week high-90.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CANFCan-Fite Biopharma Ltd$1.56+9.86%$4.7M
PCSAProcessa Pharmaceuticals Inc.$1.72-7.53%$4.8M
PULMPulmatrix Inc.$1.33+2.31%$4.9M
SCNXScienture Holdings Inc.$2.99+3.10%$4.9M
CVKDCadrenal Therapeutics Inc.$1.40-7.28%$5.0M
NCNANuCana plc American Depositary Share$0.8631-7.46%$4.4M
CNSPCNS Pharmaceuticals Inc.$3.48+20.42%$5.1M
KPRXKiora Pharmaceuticals Inc.$0.9820-20.16%$4.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier